1. Market Research
  2. > Healthcare Market Trends
  3. > CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Israel. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Israel’s population stood at approximately 8.1 million in 2013, having grown at a Compound Annual Growth Rate (CAGR) of 2.0% from 2008. Well-defined and detailed regulatory filling procedures, separate departments for the assessment of quality and safety of pharmaceutical products, and ease of access all benefit pharmaceutical players. R&D expenditure in the field of science and technology and technological advancements in healthcare are the distinguishing features of the Israeli pharmaceutical market. Gross Domestic Product (GDP) expenditure on R&D was an estimated $9.12 billion in 2013.

The pharmaceutical market was worth approximately $1.9 billion in 2013, and the Israeli pharmaceutical industry has more than 76 companies, of which 22% are involved in drug discovery and 17% in drug delivery. The pharmaceutical market is set to grow at a CAGR of 2.8% from 2008 to reach $2.3 billion in 2020. The medical device market was worth approximately $1.3 billion in 2013 and is expected to grow to approximately $1.8 billion by 2020 at a CAGR of 5.0%. These positive growth trends can be primarily attributed to -
- An increasingly elderly population
- Universal healthcare coverage
- Government initiatives

Scope

The report provides information on the Israeli healthcare, regulatory and reimbursement landscape and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Teva, Taro Pharma, Dexcel Pharma, and Rekah Pharmaceutical) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, B. Braun, Siemens Healthcare, Boston Scientific and Roche)
- An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Israel’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Israel’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in Israel’s healthcare market

Table Of Contents

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel
1 Table of Contents

2 Introduction 16
2.1 GlobalData Report Guidance 16
3 Overview of the Pharmaceutical and Medical Device Markets 17
3.1 Pharmaceutical Market 17
3.1.1 Market Overview 17
3.1.2 Pharmaceutical Exports and Imports 20
3.1.3 Supply Channels 22
3.1.4 Market Segments 22
3.1.5 Overview of Top Five Disease Areas 24
3.1.6 Major Players 26
3.2 Medical Device Market 50
3.2.1 Market Overview 50
3.2.2 Overview of Top Five Segments 52
3.2.3 Diagnostic Market 66
3.2.4 Major Players 68
3.3 Market Drivers and Barriers 102
3.3.1 Drivers 102
3.3.2 Barriers 103
4 Market Access 105
4.1 Reimbursement and Payer Landscape 105
4.1.1 Overview of Healthcare System 105
4.1.2 Reimbursement Process 106
4.1.3 Overview of Insurance Providers 107
4.1.4 Patient Share in Healthcare Spending 113
4.1.5 Price Trend in Healthcare Services 115
4.1.6 Pricing Policies 116
4.2 Regulatory Landscape 116
4.2.1 Overview of Regulatory Agencies 116
4.2.2 Market Authorization Procedure for Pharmaceutical Products 119
4.2.3 Market Authorization Procedure for Medical Devices 121
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 122
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 123
4.2.6 Intellectual Property Rights 125
4.2.7 Clinical Trial Regulations 128
4.2.8 Pharmaceutical Advertising Regulations 130
4.2.9 Pharmacy Regulations 131
4.2.10 Labeling and Packaging Regulations 132
5 Country Analysis 133
5.1 Political Environment 133
5.1.1 Political Structure 133
5.1.2 Analysis of the Current Political Environment 134
5.1.3 Healthcare Policy Initiatives 137
5.2 Economic Landscape 137
5.3 Economic Indicators 139
5.3.1 Gross Domestic Product 139
5.3.2 Gross National Income 143
5.3.3 Inflation 144
5.3.4 Currency Exchange Rate 148
5.3.5 Foreign Direct Investment 149
5.3.6 Foreign Exchange Reserves 150
5.3.7 Trade Balance 151
5.3.8 General Government Structural Balance 153
5.3.9 General Government Net Debt 154
5.3.10 Major Industries 157
5.4 Demographics 158
5.4.1 Population 158
5.4.2 Education and Literacy 179
5.4.3 Employment 182
5.4.4 Disease Burden 184
5.5 Healthcare Infrastructure 187
5.5.1 Healthcare Facilities 187
5.5.2 Healthcare Parameters 192
5.5.3 Environmental Health 195
5.5.4 Healthcare Personnel 199
5.6 Healthcare Expenditure 202
5.6.1 Overview 202
5.6.2 Public and Private Sector Share 203
5.6.3 Major Components of Healthcare Spending 205
5.6.4 Healthcare Expenditure by Financing Agent 206
5.6.5 Spending in Science and Technology Research and Development 207
5.7 Trade Associations 209
5.7.1 Pharmaceutical Association of Israel 209
5.7.2 Pharma Israel 209
5.8 Trade Fairs 210
6 Opportunities and Challenges 211
6.1 Opportunities 211
6.2 Challenges 212
7 Appendix 214
7.1 Abbreviations 214
7.2 Bibliography 218
7.3 Research Methodology 231
7.3.1 Coverage 231
7.3.2 Secondary Research 232
7.3.3 Forecasts 232
7.3.4 Expert Panel 232
7.4 Disclaimer 233

1.1 List of Tables

Table 1: Pharmaceutical Market, Israel, Revenue ($bn), 2008-2013 18
Table 2: Pharmaceutical Market, Israel, Revenue Forecast ($bn), 2014-2020 19
Table 3: Pharmaceutical Market, Israel, Pharmaceutical Exports and Imports ($m), 2008-2013 21
Table 4: Pharmaceutical Market, Israel, Over the Counter Market, Revenue ($m), 2008-2013 24
Table 5: Pharmaceutical Market, Teva, Global Revenue of Major Products, 2013 27
Table 6: Pharmaceutical Market, Teva, Late-Stage Pipeline, 2013 28
Table 7: Pharmaceutical Market, Teva, Global, Major Products, 2013 30
Table 8: Pharmaceutical Market, Taro, Global, Major Products, 2014 35
Table 9: Pharmaceutical Market, Dexcel, Israel, Products, 2014 41
Table 10: Pharmaceutical Market, Rekah, Israel, Products, 2014 46
Table 11: Medical Device Market, Israel, Revenue ($bn), 2008-2013 51
Table 12: Medical Device Market, Israel, Revenue Forecast ($bn), 2014-2020 52
Table 13: Medical Device Market, Israel, Ophthalmic Devices ($m), 2008-2013 54
Table 14: Medical Device Market, Israel, Ophthalmic Devices, Sales Trends of Major Players, 2012 55
Table 15: Medical Device Market, Israel, In Vitro Diagnostics ($m), 2008-2013 56
Table 16: Medical Device Market, Israel, In Vitro Diagnostics, Sales Trends of Major Players, 2012 57
Table 17: Medical Device Market, Israel, Nephrology and Urology Devices ($m), 2008-2013 59
Table 18: Medical Device Market, Israel, Nephrology and Urology Devices, Sales Trends of Major Players, 2012 60
Table 19: Medical Device Market, Israel, Drug Delivery Devices Market ($m), 2008-2013 61
Table 20: Medical Device Market, Israel, Drug Delivery Devices Market, Sales Trends of Major Players, 2012 62
Table 21: Medical Device Market, Israel, Cardiovascular Devices ($m), 2008-2013 64
Table 22: Medical Device Market, Israel, Cardiovascular Devices, Sales Trends of Major Players, 2012 65
Table 23: Medical Device Market, Israel, Diagnostic Market, Revenue ($bn), 2008-2013 66
Table 24: Medical Device Market, Israel, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 67
Table 25: Medical Device Market, Israel, Major Medical Device Companies Revenue, 2012 68
Table 26: Medical Device Market, Medtronic, Global, Major Products, Revenue ($bn), 2013 70
Table 27: Medical Device Market, Boston Scientific, Global, Major Products, 2014 83
Table 28: Medical Device Market, Roche, Global, Major Products, 2014 96
Table 29: Healthcare System, Israel, Contribution Rates for Insurance Based on Employment, 2014 110
Table 30: Healthcare Spending, Israel, Co-payments Cap for Chronically Ill Patients, HMO, 2014 111
Table 31: Healthcare Spending, Israel, Out-of-Pocket Expenditure (%), 2008-2013 114
Table 32: Market Access, Israel, Change in Prices of Medicines (%), 2008-2013 115
Table 33: Economic Indicators, Israel, Gross Domestic Product per Capita ($), 2008-2013 140
Table 34: Economic Indicators, Israel, Gross Domestic Product per Capita ($) Forecast, 2014-2020 141
Table 35: Economic Indicators, Israel, Gross Domestic Product Annual Growth (%), 2008-2013 142
Table 36: Economic Indicators, Israel, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 143
Table 37: Economic Indicators, Israel, Gross National Income per Capita ($), 2008-2013 144
Table 38: Economic Indicators, Israel, Average Consumer Price Index, 2008-2013 145
Table 39: Economic Indicators, Israel, Average Consumer Price Index Forecast, 2014-2020 146
Table 40: Economic Indicators, Israel, Average Consumer Price Annual Change (%), 2008-2013 147
Table 41: Economic Indicators, Israel, Currency Exchange Rate (ILS/$), 2008-2013 148
Table 42: Economic Indicators, Israel, Foreign Direct Investment ($bn), 2008-2013 149
Table 43: Economic Indicators, Israel, Foreign Exchange Reserves ($bn), 2008-2013 150
Table 44: Economic Indicators, Israel, Imports of Goods and Services ($bn), 2008-2013 152
Table 45: Economic Indicators, Israel, Exports of Goods and Services ($bn), 2008-2013 153
Table 46: Economic Indicators, Israel, Government Structural Balance ($bn), 2008-2013 154
Table 47: Economic Indicators, Israel, General Government Net Debt (% of GDP), 2008-2013 155
Table 48: Economic Indicators, Israel, General Government Net Debt (% of GDP) Forecast, 2014-2020 156
Table 49: Economic Indicators, Israel, Major Industries by Revenue (%), 2012 158
Table 50: Demographics, Israel, Population (million), 2008-2013 159
Table 51: Demographics, Israel, Population Forecast (million), 2014-2020 160
Table 52: Demographics, Israel, Population, Urban and Rural Population Share (%), 2008-2013 162
Table 53: Demographics, Israel, Population, Urban and Rural Population Share Forecast (%), 2014-2020 163
Table 54: Demographics, Israel, Population Distribution by Age Group (%), 2008-2013 164
Table 55: Demographics, Israel, Population Distribution by Age Group Forecast (%), 2014-2020 165
Table 56: Demographics, Israel, Births (per 1,000 Population), 2008-2013 166
Table 57: Demographics, Israel, Mortality (per 1,000 Population), 2008-2013 167
Table 58: Demographics, Israel, Major Causes of Mortality, 2011 169
Table 59: Demographics, Israel, Infant Mortality (per 1,000 Live Births), 2008-2013 170
Table 60: Demographics, Israel, Immunization Rate (%), 2008-2010 172
Table 61: Demographics, Israel, Major Causes of Male Mortality (per 100,000 population), 2013 174
Table 62: Demographics, Israel, Major Causes of Female Mortality (per 100,000 population), 2013 176
Table 63: Demographics, Israel, Gender Ratio (M/F), 2008-2013 177
Table 64: Demographics, Israel, Life Expectancy at Birth (Years), 2008-2013 179
Table 65: Demographics, Israel, Enrollment by Level of Education (%), 2009-2013 181
Table 66: Demographics, Israel, Enrollment Rate by Supervision of the Education System (%), 2011-2012 182
Table 67: Demographics, Israel, Unemployment Rate (%), 2008-2013 183
Table 68: Demographics, Israel, Distribution of Employment by Occupation (%), 2012 184
Table 69: Demographics, Israel, Number of Reported Cases per Disease (per 1,000 Population), 2009 185
Table 70: Demographics, Israel, Major Diseases, Disability-Adjusted Life Years (per 100,000 Population), 2004 187
Table 71: Healthcare Infrastructure, Israel, Number of Hospital Establishments, 2008-2013 188
Table 72: Healthcare Infrastructure, Israel, Public and Private Hospitals, 2008-2013 189
Table 73: Healthcare Infrastructure, Israel, Type of Hospital Care, 2008-2013 191
Table 74: Healthcare Infrastructure, Israel, Diagnostic Equipment (per Million Population), 2008-2013 192
Table 75: Healthcare Infrastructure, Israel, Hospital Beds (per 1,000 Population), 2008-2013 193
Table 76: Healthcare Infrastructure, Israel, Doctors (per 1,000 Population), 2008-2013 194
Table 77: Healthcare Infrastructure, Israel, PM10 (µg/m3), 2008-2013 196
Table 78: Healthcare Infrastructure, Israel, Carbon Dioxide Emissions (Million Metric Tons), 2008-2013 197
Table 79: Healthcare Infrastructure, Israel, Nitrogen Oxide Emissions (Million Metric Tons), 2008-2013 198
Table 80: Healthcare Infrastructure, Israel, Nurses (per 1,000 Population), 2008-2013 199
Table 81: Healthcare Infrastructure, Israel, Pharmacists (per 1,000 Population), 2008-2013 200
Table 82: Healthcare Infrastructure, Israel, Dentists (per 1,000 Population), 2008-2013 201
Table 83: Healthcare Expenditure, Israel, Healthcare Expenditure (% of GDP), 2008-2013 203
Table 84: Healthcare Expenditure, Israel, Healthcare Expenditure, Public-Private Share (%), 2008-2013 204
Table 85: Healthcare Expenditure, Israel, Primary Healthcare Expenditure by Sector (%), 2010 205
Table 86: Healthcare Expenditure, Israel, Healthcare Expenditure Financing Agent (%), 2010 206
Table 87: Healthcare Expenditure, Israel, Gross Domestic Product Expenditure on Research and Development in Sciences ($bn), 2008-2013 208
Table 88: Healthcare Expenditure, Israel, Expenditure for Specially Funded Research by Sector (%), 2009 208
Table 89: Healthcare Expenditure, Israel, Major Healthcare Trade Fairs, 2014 210

1.2 List of Figures
Figure 1: Pharmaceutical Market, Israel, Revenue ($bn), 2008-2013 18
Figure 2: Pharmaceutical Market, Israel, Revenue Forecast ($bn), 2014-2020 19
Figure 3: Pharmaceutical Market, Israel, Pharmaceutical Exports and Imports ($m), 2008-2013 21
Figure 4: Pharmaceutical Market, Israel, Over the Counter Market, Revenue ($m), 2008-2013 24
Figure 5: Medical Device Market, Israel, Revenue ($bn), 2008-2013 51
Figure 6: Medical Device Market, Israel, Revenue Forecast ($bn), 2014-2020 52
Figure 7: Medical Device Market, Israel, Ophthalmic Devices ($m), 2008-2013 53
Figure 8: Medical Device Market, Israel, Ophthalmic Devices, Sales Trends of Major Players, Revenue ($m), 2008-2012 54
Figure 9: Medical Device Market, Israel, In Vitro Diagnostics ($m), 2008-2013 56
Figure 10: Medical Device Market, Israel, In Vitro Diagnostics, Sales Trends of Major Players, Revenue ($m), 2008-2012 57
Figure 11: Medical Device Market, Israel, Nephrology and Urology Devices ($m), 2008-2013 58
Figure 12: Medical Device Market, Israel, Nephrology and Urology Devices, Sales Trends of Major Players, Revenue ($m), 2008-2012 59
Figure 13: Medical Device Market, Israel, Drug Delivery Devices Market ($m), 2008-2013 61
Figure 14: Medical Device Market, Israel, Drug Delivery Devices Market, Sales Trends of Major Players, Revenue ($m), 2008-2012 62
Figure 15: Medical Device Market, Israel, Cardiovascular Devices ($m), 2008-2013 64
Figure 16: Medical Device Market, Israel, Cardiovascular Devices, Sales Trends of Major Players, Revenue ($m), 2008-2012 65
Figure 17: Medical Device Market, Israel, Diagnostic Market, Revenue ($bn), 2008-2013 66
Figure 18: Medical Device Market, Israel, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 67
Figure 19: Medical Device Market, Israel, Major Medical Device Companies Revenue ($m), 2012 68
Figure 20: Healthcare Market, Israel, Drivers and Barriers, 2014 104
Figure 21: Healthcare System, Israel, Overview of Healthcare System, 2014 106
Figure 22: Healthcare Spending, Israel, Out-of-Pocket Expenditure (%), 2008-2013 114
Figure 23: Market Access, Israel, Change in Prices of Medicines (%), 2008-2013 115
Figure 24: Market Access, Israel, Overview of Regulatory Bodies, 2014 119
Figure 25: Economic Indicators, Israel, Gross Domestic Product Per Capita ($), 2008-2013 140
Figure 26: Economic Indicators, Israel, Gross Domestic Product per Capita ($) Forecast, 2014-2020 141
Figure 27: Economic Indicators, Israel, Gross Domestic Product Annual Growth (%), 2008-2013 142
Figure 28: Economic Indicators, Israel, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 143
Figure 29: Economic Indicators, Israel, Gross National Income per Capita ($), 2008-2013 144
Figure 30: Economic Indicators, Israel, Average Consumer Price Index, 2008-2013 145
Figure 31: Economic Indicators, Israel, Average Consumer Price Index Forecast, 2014-2020 146
Figure 32: Economic Indicators, Israel, Average Consumer Price Annual Change (%), 2008-2013 147
Figure 33: Economic Indicators, Israel, Currency Exchange Rate (ILS/$), 2008-2013 148
Figure 34: Economic Indicators, Israel, Foreign Direct Investment ($bn), 2008-2013 149
Figure 35: Economic Indicators, Israel, Foreign Exchange Reserves ($bn), 2008-2013 150
Figure 36: Economic Indicators, Israel, Imports of Goods and Services ($bn), 2008-2013 151
Figure 37: Economic Indicators, Israel, Exports of Goods and Services ($bn), 2008-2013 152
Figure 38: Economic Indicators, Israel, Government Structural Balance ($bn), 2008-2013 154
Figure 39: Economic Indicators, Israel, General Government Net Debt (% of GDP), 2008-2013 155
Figure 40: Economic Indicators, Israel, General Government Net Debt (% of GDP) Forecast, 2014-2020 156
Figure 41: Economic Indicators, Israel, Major Industries by Revenue (%), 2012 157
Figure 42: Demographics, Israel, Population (million), 2008-2013 159
Figure 43: Demographics, Israel, Population Forecast (million), 2014-2020 160
Figure 44: Demographics, Israel, Population, Urban and Rural Population Share (%), 2008-2013 161
Figure 45: Demographics, Israel, Population, Urban and Rural Population Share Forecast (%), 2014-2020 162
Figure 46: Demographics, Israel, Population Distribution by Age Group (%), 2008-2013 164
Figure 47: Demographics, Israel, Population Distribution by Age Group Forecast (%), 2014-2020 165
Figure 48: Demographics, Israel, Births (per 1,000 Population), 2008-2013 166
Figure 49: Demographics, Israel, Mortality (per 1,000 Population), 2008-2013 167
Figure 50: Demographics, Israel, Major Causes of Mortality, 2011 168
Figure 51: Demographics, Israel, Infant Mortality (per 1,000 Live Births), 2008-2013 170
Figure 52: Demographics, Israel, Immunization Rate (%), 2008-2010 171
Figure 53: Demographics, Israel, Major Causes of Male Mortality (per 100,000 population), 2013 173
Figure 54: Demographics, Israel, Major Causes of Female Mortality (per 100,000 population), 2013 175
Figure 55: Demographics, Israel, Gender Ratio (M/F), 2008-2013 177
Figure 56: Demographics, Israel, Life Expectancy at Birth (Years), 2008-2013 178
Figure 57: Demographics, Israel, Enrollment by Level of Education (%), 2009-2013 180
Figure 58: Demographics, Israel, Enrollment Rate by Supervision of the Education System (%), 2011-2012 182
Figure 59: Demographics, Israel, Unemployment Rate (%), 2008-2013 183
Figure 60: Demographics, Israel, Distribution of Employment by Occupation (%), 2012 184
Figure 61: Demographics, Israel, Number of Reported Cases per Disease (per 1,000 Population), 2009 185
Figure 62: Demographics, Israel, Major Diseases, Disability-Adjusted Life Years (per 100,000 Population), 2004 186
Figure 63: Healthcare Infrastructure, Israel, Number of Hospital Establishments, 2008-2013 188
Figure 64: Healthcare Infrastructure, Israel, Public and Private Hospitals, 2008-2013 189
Figure 65: Healthcare Infrastructure, Israel, Type of Hospital Care, 2008-2013 190
Figure 66: Healthcare Infrastructure, Israel, Diagnostic Equipment (per Million Population), 2008-2013 191
Figure 67: Healthcare Infrastructure, Israel, Hospital Beds (per 1,000 Population), 2008-2013 193
Figure 68: Healthcare Infrastructure, Israel, Doctors (per 1,000 Population), 2008-2013 194
Figure 69: Healthcare Infrastructure, Israel, PM10 (µg/m3), 2008-2013 196
Figure 70: Healthcare Infrastructure, Israel, Carbon Dioxide Emissions (Million Metric Tons), 2008-2013 197
Figure 71: Healthcare Infrastructure, Israel, Nitrogen Oxide Emissions (Million Metric Tons), 2008-2013 198
Figure 72: Healthcare Infrastructure, Israel, Nurses (per 1,000 Population), 2008-2013 199
Figure 73: Healthcare Infrastructure, Israel, Pharmacists (per 1,000 Population), 2008-2013 200
Figure 74: Healthcare Infrastructure, Israel, Dentists (per 1,000 Population), 2008-2013 201
Figure 75: Healthcare Expenditure, Israel, Healthcare Expenditure (% of GDP), 2008-2013 202
Figure 76: Healthcare Expenditure, Israel, Healthcare Expenditure, Public-Private Share (%), 2008-2013 204
Figure 77: Healthcare Expenditure, Israel, Primary Healthcare Expenditure by Sector (%), 2010 205
Figure 78: Healthcare Expenditure, Israel, Healthcare Expenditure Financing Agent (%), 2010 206
Figure 79: Healthcare Expenditure, Israel, Gross Domestic Product Expenditure on Research and Development in Sciences ($bn), 2008-2013 207
Figure 80: Healthcare Expenditure, Israel, Expenditure for Specially Funded Research by Sector (%), 2009 208
Figure 81: Healthcare Market, Israel, Opportunities and Challenges, 2014 21

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.